MDGL vs PG · rev $180.1M vs P/E 25, rev $84.28B
Madrigal Pharmaceuticals Inc (MDGL) versus Procter & Gamble Company (PG) — a side-by-side from cached financials, not a winner call.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Latest reported MDGL revenue for 2024-12-31 was $180.1M. Net income was -$465.9M. MDGL currently screens at market cap $11.56B.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
MDGL currently screens at market cap $11.56B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Not investment advice. Open the MDGL and PG stock pages for the full models.
Not investment advice.